Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078287/0/en/LENZ-Therapeutics-and-Lotus-Pharmaceutical-Announce-Exclusive-License-and-Commercialization-Agreement-for-LNZ100-in-the-Republic-of-Korea-and-Southeast-Asia.html
05 Feb 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-02-05/lotus-pharmaceutical-becomes-strategic-partner-for-the-commercialization-of-formycon-s-eylea-biosim
12 Jun 2024
// BIOSPECTRUM ASIA
https://www.biospectrumasia.com/news/25/24415/taiwans-lotus-pharma-acquires-teva-pharma-thailand-expanding-footprint-in-southeast-asia.html
11 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaq-nrxp-announces-advance-of-5-million-milestone-payment-from-partners-alvogen-inc-and-lotus-pharmaceutical-co-ltd-1975tw-302059100.html
02 Sep 2016
// FDA
https://www.pharmacompass.com/pdf/news/lotus-pharms-generic-levonorgestrel-approved-in-us-1473506867.pdf
https://www.pharmacompass.com/pdf/news/lotus-pharms-generic-paricalcitol-approved-in-us-for-treatment-of-secondary-hyperparathyroidism-1456398078.pdf
Inspections and registrations
ABOUT THIS PAGE
Lotus Pharmaceutical is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of TM-1 (N-[2-(2-METHOXYPHENOXY)ETHYL]NORGLAUCINE) bulk offered by Lotus Pharmaceutical